reMYND drives the development of disease-modifying treatments against protein misfolding disorders.

Biotechnology

reMYND

Gerard Griffioen

Marc Fivaz

David Devigne

Ajit Shetty

Paul Van Dun

Jeffrey Cummings

Rudy Dekeyser

Henrik Zetterberg

Kaj Blennow

Goedele Ertveldt

Filip Goossens

The Clinical Advisory Team at reMYND provides expert guidance on clinical trial design, implementation, and interpretation to advance the development of treatments for protein misfolding disorders. Their insights help ensure that the clinical strategies are scientifically sound and aligned with regulatory standards, thereby optimizing patient outcomes and accelerating the path to market.

Clinical Advisory Team

The Leadership Team at reMYND is responsible for setting the strategic vision and direction of the company, guiding research and development efforts in disease-modifying treatments for protein misfolding disorders. Comprising experts in scientific and business domains, the team collaborates to drive innovation, oversee operational excellence, and foster partnerships to advance therapeutic solutions and improve patient outcomes.

Leadership Team

reMYND

Org chart

Board & advisors

Teams

Clinical Advisory Team

Leadership Team

Offices

reMYND

Org chart

Board & advisors

Teams

Clinical Advisory Team

Leadership Team

Offices

Related companies